Asian Spectator

Times Advertising

CSL Vifor and Travere Therapeutics announce standard EU approval for FILSPARI® in IgA Nephropathy

  • Written by PR Newswire Asia - Asian Spectator
CSL Vifor and Travere Therapeutics announce standard EU approval for FILSPARI® in IgA NephropathyCSL Vifor and Travere Therapeutics announce standard EU approval for FILSPARI® in IgA Nephropathy

European Commission converts conditional approval of FILSPARI (sparsentan) into standard marketing authorization for the treatment of IgA Nephropathy (IgAN)

Decision follows positive recommendation from Committee for Medicinal Products for Human Use (CHMP) from February 2025

EU approval is based on the complete data set from the phase-III...

Magazine

Ancaman blokir Wikipedia: Tanda kuatnya hasrat negara mengontrol narasi publik

shutterstock(Pixinoo/Shutterstock)● Ancaman blokir Wikipedia menandai obsesi negara memperluas kontrol atas infrastruktur pengetahuan publik.● Regulasi menjadi instrumen yang memaksa platf...

Bukan cuma ikan sapu-sapu, ada banyak spesies invasif di perairan kita termasuk ikan nila

● Spesies invasif seperti ikan sapu-sapu, red devil, ikan cere, dan nila merupakan ancaman serius bagi ikan-ikan lokal.● Penyebaran spesies invansif terjadi akibat aktivitas manusia (perda...

Toleransi di ruang digital: Bagaimana tayangan Youtube ‘Login’ menggeser metode dakwah konvensional

● Media sosial mengubah ekspresi toleransi yang kaku, elitis, dan ‘top-down’ menjadi lebih cair dan egaliter.● Program seperti ‘Login’ membumikan isu agama yang ber...